Merck known as MSD outside the United States and Canada, announced today it has entered into multiple agreements to support efforts to expand manufacturing capacity and supply of SARS-CoV-2COVID-19 medicines and vaccines. The Biomedical Advanced Research and Development Authority a division of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services … Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today it has entered into multiple agreements to support efforts to expand manufacturing capacity and supply of SARS-CoV-2/COVID-19 medicines and vaccines. The Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), will provide Merck with funding of up to $268.8 million to adapt and make available a number of existing manufacturing
Merck & Co to help produce J&J s COVID-19 vaccine in the US
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
Merck enters agreements for supply of Covid-19 medicines and vaccines
pharmaceutical-business-review.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-business-review.com Daily Mail and Mail on Sunday newspapers.
February 23, 2021
×
The country can scale in vaccine manufacturing, supply value chain, says Sanat Chattopadhyay, Executive Vice-President and President, Merck Manufacturing Division Indian pharmaceutical companies, who have been playing a major role in global supply chains with supplies of generics, now have the potential to scale up the value chain, according to Sanat Chattopadhyay, Executive Vice-President and President, Merck Manufacturing Division.
Delivering his address at BioAsia 2021, a life-sciences and healthcare forum, being hosted in Hyderabad, he said: “In the last one year, a tsunami of changes has been unleashed, causing havoc on the global pharmaceutical industry. Our purpose at Merck is to improve access to life-saving therapeutics and vaccines across the world.”